• Stock rises 10.16% to ₹15.84, extending recent recovery trend
  • Profit stands at ₹515.20 lakh, supporting improving fundamentals
  • RSI nears overbought zone, indicating possible short-term pause

Overview

Anlon Healthcare (NSE: ANLON) moved higher to ₹15.84, gaining 10.16% and continuing its recent upward momentum. The stock has been recovering steadily after a phase of consolidation, with the latest move indicating a possible breakout attempt toward higher levels.

The price action shows improving strength, with higher highs and higher lows forming over recent sessions. This suggests a shift from a weak structure into a gradual recovery phase. However, the stock is now approaching a key resistance zone, where the next directional move will be crucial.

The broader setup remains constructive, but the pace of the rally indicates that the stock may soon test its near-term limits.

Fundamental View

For the quarter ended December 2025, the company reported total income of ₹3,578.05 lakh. Profit before tax stood at ₹1,061.33 lakh, while net profit came in at ₹515.20 lakh. Earnings per share was reported at ₹1.13.

The profitability indicates stable operational performance for a small-cap healthcare player. While growth remains moderate, the company has maintained positive earnings, which provides some support to the ongoing price recovery.

However, the scale of operations remains relatively small, and sustainability of earnings growth will be important for long-term re-rating. The current rally appears to be a mix of improving sentiment and technical momentum rather than a sharp fundamental re-rating.

Technical View

Technically, Anlon Healthcare is showing a steady recovery with a sequence of higher lows, indicating improving trend structure. The stock has moved above recent consolidation zones, suggesting accumulation at lower levels.

The latest candle reflects strong upward movement, pushing prices closer to resistance. However, the move is not as vertical as some high-momentum stocks, indicating a more controlled recovery.

The RSI is around 79.29, entering overbought territory. This suggests that momentum is strong but stretched, and the stock may see consolidation or mild pullback before attempting further upside.

Overall, the trend remains positive, but the stock is approaching a decision zone.

Key Technical Levels

The stock is approaching a support zone of ₹14.10–₹12.90, which may act as a base if prices correct from current levels. Holding above this range will be important to sustain the improving trend.

On the upside, resistance is placed at ₹17.20–₹18.50. This zone could act as a near-term hurdle, where the stock may face selling pressure.

Source: TradingView

Risks To Watch

• Overbought RSI indicating pullback risk
  • Limited scale of earnings growth
  • Volatility near resistance levels
  • Momentum-driven rally without strong triggers

Summary

Anlon Healthcare’s recent rally reflects a steady recovery supported by improving price structure and stable earnings. The stock is now approaching key resistance levels, where the next move will determine trend continuation.

With RSI in overbought territory, consolidation or mild correction cannot be ruled out in the near term. Sustaining above support will be critical for maintaining the current upward bias.

FAQs

Why is Anlon Healthcare stock rising?
The stock is gaining due to technical recovery and stable earnings performance.

Is the stock overbought?
Yes, RSI is above 70, indicating overbought conditions.

What levels should be tracked?
Support is at ₹14.10–₹12.90, while resistance lies at ₹17.20–₹18.50.